Form 4: BioCorRx Inc. Director Lucido Acquires Shares as Part of Compensation Agreements

Louis C. Lucido, a director, 10% owner, and President of BioCorRx Inc., acquired shares of common stock on March 28, 2024, as part of his director and executive service agreements.

Summary

• On March 28, 2024, Louis C. Lucido acquired 5,566 shares of BioCorRx Inc. common stock as compensation for his services as a director.
• These shares were issued under a Director Agreement dated March 1, 2019, where he receives shares equivalent to $5,000 per fiscal quarter.
• Additionally, Mr. Lucido acquired 18,553 shares under an Executive Service Agreement dated January 5, 2024, receiving shares equivalent to $16,666.66 per month.
• The average closing price used to calculate the number of shares issued was $0.90.
• Following these transactions, Mr. Lucido beneficially owns 534,213 shares of BioCorRx Inc. common stock.

Sentiment

Score: 7

Explanation: The document reflects standard compensation practices and insider ownership transparency, which is generally viewed neutrally to positively. The ongoing compensation agreements suggest a continued commitment from the executive.

Positives

• The share issuances reflect ongoing compensation to a key executive and director, aligning his interests with the company's performance.
• The agreements provide a structured and transparent method for compensating Mr. Lucido.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency regarding the compensation and ownership stakes of key personnel.

Stakeholder Impact

• The share issuances dilute existing shareholders to a small degree.
• The transactions ensure continued alignment of management's interests with those of shareholders.

Key Dates

Keywords

BioCorRx Inc., Louis C. Lucido, share acquisition, Director Agreement, Executive Service Agreement, beneficial ownership, Form 4, BICX